⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7622829 | 0.96 | — | — | |
| SCHEMBL8532732 | 0.81 | — | — | |
| SCHEMBL8536231 | 0.81 | — | — | |
| SCHEMBL7055319 | 0.80 | — | — | |
| SCHEMBL7055318 | 0.79 | — | — | |
| SCHEMBL7059057 | 0.79 | — | — | |
| SCHEMBL7549368 | 0.78 | — | — | |
| SCHEMBL9210894 | 0.77 | — | — | |
| SCHEMBL9210887 | 0.77 | — | — | |
| SCHEMBL9210719 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020128300-A1 | Treating diabetic retinopathy in a mammal by administering an angiotensin II receptor antagonist. | SMITHKLINE BEECHAM P.L.C. | 2002-09-12 | — | — | US | disclosed |